Photo from academic.microsoft.com
Gadolinium-based contrast agents (GBCAs) are widely used in MRI to increase the visibility of tissues. Some believe, however, that due to their documented toxicity, clinical use of these agents should… Click to show full abstract
Gadolinium-based contrast agents (GBCAs) are widely used in MRI to increase the visibility of tissues. Some believe, however, that due to their documented toxicity, clinical use of these agents should be discontinued until proven safe. This is the premise debated in this month's Point/Counterpoint. This article is protected by copyright. All rights reserved.
Keywords:
contrast agents;
discontinued proven;
proven safe;
gadolinium based;
based contrast;
agents discontinued
Journal Title: Medical physics
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Medical physics
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!